Premaitha Health PLC Company Profile (LON:NIPT)

Analyst Ratings

Consensus Ratings for Premaitha Health PLC (LON:NIPT) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 22

Analysts' Ratings History for Premaitha Health PLC (LON:NIPT)
Show:
DateFirmActionRatingPrice TargetActions
7/4/2016Panmure GordonReiterated RatingBuyGBX 24View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/4/2016FinnCapReiterated RatingCorporateGBX 20View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Premaitha Health PLC (LON:NIPT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Premaitha Health PLC (LON:NIPT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Premaitha Health PLC (LON:NIPT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Premaitha Health PLC (LON:NIPT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/17/2015Hextall,Barry KennethInsiderBuy180,736GBX 18£32,532.48Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Premaitha Health PLC (LON:NIPT)
DateHeadline
07/04/16 04:48 PMPremaitha Health Plc (LON:NIPT) target price held steady to GBX20, reported today by finnCap
07/04/16 10:08 AMPremaitha Health Plc (LON:NIPT) price target maintained to GBX24 as reported today by Panmure Gordon
07/04/16 01:11 AMProgress on anti-trust objections to litigation - [at noodls] - Premaitha Health plc Manchester, UK- 4 July 2016: Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, provides an update on anti-trust ...
06/22/16 05:18 PMPremaitha Health : Adoption of Financial Reporting Standard (FRS) 101
02/26/16 12:06 PMWeekly Broker Update - Premaitha Health (LON:NIPT) - Risers & Fallers - Weekly Broker Update - Premaitha Health (LON:NIPT)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Premaitha Health (LON:NIPT). The latest broker reports which are currently ... Premaitha Health had its “Buy” rating reiterated by analysts at Panmure Gordon. They now ...and more »
02/14/16 01:37 PMCould Premaitha Health PLC Change Direction After Today's Huge Increase? - Sonoran Weekly Review - Could Premaitha Health PLC Change Direction After Today's Huge Increase?Sonoran Weekly ReviewThe stock of Premaitha Health PLC (LON:NIPT) is a huge mover today! The stock is down 1.02% or GBX 0.15 after the news, hitting GBX 14.6 per share. About 27,390 shares traded hands. Premaitha Health PLC (LON:NIPT) has declined 32.18% since July ...and more »
02/03/16 01:08 PMPremaitha Health partners with Visional Medical to provide the IONA test to pregnant women in India - FierceMedicalDevices (press release) (registration) - DIGITALLOOKPremaitha Health partners with Visional Medical to provide the IONA test to pregnant women in IndiaFierceMedicalDevices (press release) (registration)Manchester, UK and Chennai, India – 3 February 2016 – Premaitha Health plc (AIM: NIPT, "Premaitha" or "the Company") developer of the IONA® test, the first CE-marked non-invasive prenatal screening (NIPT) product, has signed an agreement with ...Premaitha Health Signs Deal With Visional Medical For Indian MarketLondon South East (registration) (blog)all 8 news articles »
02/03/16 01:08 PMPanmure Gordon Keeps Premaitha Health Plc (LON:NIPT) As Buy; Has Target Of GBX 24.00 - OctaFinance.com - Risers & FallersPanmure Gordon Keeps Premaitha Health Plc (LON:NIPT) As Buy; Has Target Of GBX 24.00OctaFinance.comIn a research note issued to clients and investors on 2 February, Premaitha Health Plc (LON:NIPT) stock had its Buy Rating reiterated by analysts at Panmure Gordon. They currently have a GBX 24.00 price target on firm. Panmure Gordon's target indicates ...Premaitha Health PLC's (NIPT) "Buy" Rating Reiterated at Panmure GordonIRA Market ReportPremaitha Health Plc (LON:NIPT) Receives Buy Rating From Panmure Gordon AnalystsRisers & FallersPremaitha Health PLC (NIPT) Stock Rating Reaffirmed by Panmure GordonZolmaxWallStreet.orgall 1,952 news articles »
02/03/16 02:46 AMPremaitha propels prenatal test into Indian market -
02/02/16 01:15 AMPremaitha partners with Leeds Hospitals NHS Trust - [at noodls] - Premaitha Health PLC Premaitha Health partners with Leeds Teaching Hospitals NHS Trust to offer pregnant women safer non-invasive prenatal screening service Manchester and Leeds, UK - 2 February 2016- ...
01/29/16 01:02 PMJanuary News and Product Briefs - Bio-IT World - January News and Product BriefsBio-IT WorldThe suits concern the use of Ariosa's Harmony NIPT test by The Doctors Laboratory in the United Kingdom, and Premaitha Health's Iona NIPT test by multiple labs in Poland. Illumina is also engaged in ongoing suits against both Ariosa and Premaitha.
01/28/16 01:18 AMHardman & Co Research Report: IONA�-Up and running - [at noodls] - Hardman & Co issues research report on Premaitha Health IONA™ - Up, running and available on the NHS: Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening ...
01/27/16 12:26 PMRecent Broker Updates On Premaitha Health (LON:NIPT) - Risers & Fallers - Recent Broker Updates On Premaitha Health (LON:NIPT)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Premaitha Health (LON:NIPT). The latest broker reports which are currently ... Premaitha Health had its “Buy” rating reiterated by analysts at Panmure Gordon. They now ...and more »
01/27/16 12:26 PMPremaitha Health signs two new customers for its clinical laboratory NIPT screening service - FierceMedicalDevices (press release) (registration) - Proactive Investors USA & CanadaPremaitha Health signs two new customers for its clinical laboratory NIPT screening serviceFierceMedicalDevices (press release) (registration)Manchester, UK – 27 January 2016 – Premaitha Health PLC (AIM: NIPT, "Premaitha" or the "Company"), developer of the IONA® test, the first CE-marked non-invasive prenatal screening (NIPT) product has signed two new service contracts with customers in ...Premaitha Health Signs Service Contracts In Armenia And MoldovaLondon South East (registration) (blog)all 6 news articles »
01/27/16 11:05 AMPremaitha expands prenatal product into two new markets -
01/17/16 06:39 PMREPEAT: Premaitha Welcomes Recommendation On NHS Pre-Natal Screening - London South East (registration) (blog) - REPEAT: Premaitha Welcomes Recommendation On NHS Pre-Natal ScreeningLondon South East (registration) (blog)LONDON (Alliance News) - Premaitha Health PLC on Friday welcomed the recommendation made by the UK National Screening Committee to routinely-offer non-invasive pre-natal testing on the NHS to high-risk pregnant women as part of a standard fetal anomaly ...and more »
01/15/16 01:19 AMPremaitha welcomes NSC recommendation on NIPT - [at noodls] - Premaitha Health PLC Premaitha Health welcomes recommendation for NHS provision of non-invasive prenatal testing National Screening Committee recommendation will enable more pregnant women to benefit from ...
01/08/16 11:55 AMUpdate on competitor patent litigation - [at noodls] - Premaitha Health PLC Manchester, UK - 8 January 2016- Premaitha Health PLC (AIM: NIPT, 'Premaitha' or the 'Company'), developer of the IONA® test, the first CE-marked non-invasive prenatal (NIPT) in vitrodiagnostic ...
12/14/15 10:42 AMPremaitha Health confident about full year after Thermo Fisher deal -
12/14/15 06:07 AMHalf Year 2016 Premaitha Health PLC Earnings Release - Time Not Supplied -
12/14/15 01:17 AMPremaitha Health PLC Premaitha Health signs Investment Agreement with Thermo Fisher Scientific -
12/14/15 01:14 AMInvestment Agreement with Thermo Fisher Scientific - [at noodls] - Premaitha Health PLC Premaitha Health signs Manchester, UK - 14 December 2015: Premaitha Health PLC (AIM: NIPT, 'Premaitha' or the 'Company') signs an agreement for Thermo Fisher Scientific to provide ...
12/02/15 01:17 AMFirst IONA� testing service in France at LaboSud - [at noodls] - Financial Express (Holdings) Limited ('we', 'our', 'us' and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis ...

Social

About Premaitha Health PLC

Premaitha Health PLC logoPremaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques. The Company's techniques are used for pre-natal screening (NIPT) and other clinical applications in the early detection, monitoring and treatment of disease. The Company operates through two segments: Head office and Operations. The Operations segment is involved in a molecular diagnostics business in the United Kingdom, and sales technology development in the United States. The Company's flagship product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated NIPT in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The IONA test directly measures alterations in deoxyribonucleic acid ratios in the maternal plasma when fetal trisomy 21, 18 or 13 is present.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: NIPT
  • CUSIP:
Key Metrics:
  • Previous Close: $0.13
  • 50 Day Moving Average: $8.855
  • 200 Day Moving Average: $10.749
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $20.55M
  • Current Year EPS Consensus Estimate: $-2.340 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: